Selected research
Market Analysis & Forecast
Global Cosmetic In Vitro Testing Services Market Analysis and Forecast 2026-2032
Market perspective
The global Cosmetic In Vitro Testing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Cosmetic In Vitro Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Cosmetic In Vitro Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Cosmetic In Vitro Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Cosmetic In Vitro Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Cosmetic In Vitro Testing Services include SGS, Intertek, Eurofins Scientific, Abich, XCellR8, ImQuest BioSciences, INVITRO-CONNECT, Labcorp and Bio-Rad Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Cosmetic In Vitro Testing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Cosmetic In Vitro Testing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Cosmetic In Vitro Testing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cosmetic In Vitro Testing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cosmetic In Vitro Testing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cosmetic In Vitro Testing Services revenue, projected growth trends, production technology, application and end-user industry.
Cosmetic In Vitro Testing Services Segment by Company
SGS
Intertek
Eurofins Scientific
Abich
XCellR8
ImQuest BioSciences
INVITRO-CONNECT
Labcorp
Bio-Rad Laboratories
Qiagen
GE Healthcare
Charles River Laboratories International
Catalent
Evotec Cyprotex
Promega
Gentronix Limited
Cosmetic In Vitro Testing Services Segment by Type
Biological Assays
Non-cell-based Assays
Cosmetic In Vitro Testing Services Segment by Application
Hair Care
Skin Care
Others
Cosmetic In Vitro Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cosmetic In Vitro Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cosmetic In Vitro Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cosmetic In Vitro Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Cosmetic In Vitro Testing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Cosmetic In Vitro Testing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cosmetic In Vitro Testing Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biological Assays
- Non-cell-based Assays
Applications
- Hair Care
- Skin Care
- Others
Companies covered
- SGS
- Intertek
- Eurofins Scientific
- Abich
- XCellR8
- ImQuest BioSciences
- INVITRO-CONNECT
- Labcorp
- Bio-Rad Laboratories
- Qiagen
- GE Healthcare
- Charles River Laboratories International
- Catalent
- Evotec Cyprotex
- Promega
- Gentronix Limited
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Cosmetic In Vitro Testing Services Market by Type
- 1.2.1 Global Cosmetic In Vitro Testing Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Biological Assays
- 1.2.3 Non-cell-based Assays
- 1.3 Cosmetic In Vitro Testing Services Market by Application
- 1.3.1 Global Cosmetic In Vitro Testing Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hair Care
- 1.3.3 Skin Care
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cosmetic In Vitro Testing Services Market Dynamics
- 2.1 Cosmetic In Vitro Testing Services Industry Trends
- 2.2 Cosmetic In Vitro Testing Services Industry Drivers
- 2.3 Cosmetic In Vitro Testing Services Industry Opportunities and Challenges
- 2.4 Cosmetic In Vitro Testing Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Cosmetic In Vitro Testing Services Market Perspective (2021-2032)
- 3.2 Global Cosmetic In Vitro Testing Services Growth Trends by Region
- 3.2.1 Global Cosmetic In Vitro Testing Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Cosmetic In Vitro Testing Services Market Size by Region (2021-2026)
- 3.2.3 Global Cosmetic In Vitro Testing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Cosmetic In Vitro Testing Services Revenue by Players
- 4.1.1 Global Cosmetic In Vitro Testing Services Revenue by Players (2021-2026)
- 4.1.2 Global Cosmetic In Vitro Testing Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Cosmetic In Vitro Testing Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Cosmetic In Vitro Testing Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Cosmetic In Vitro Testing Services Key Players Headquarters & Area Served
- 4.4 Global Cosmetic In Vitro Testing Services Players, Product Type & Application
- 4.5 Global Cosmetic In Vitro Testing Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Cosmetic In Vitro Testing Services Market CR5 and HHI
- 4.6.3 2025 Cosmetic In Vitro Testing Services Tier 1, Tier 2, and Tier 3
5 Cosmetic In Vitro Testing Services Market Size by Type
- 5.1 Global Cosmetic In Vitro Testing Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Cosmetic In Vitro Testing Services Revenue by Type (2021-2032)
- 5.3 Global Cosmetic In Vitro Testing Services Revenue Market Share by Type (2021-2032)
6 Cosmetic In Vitro Testing Services Market Size by Application
- 6.1 Global Cosmetic In Vitro Testing Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Cosmetic In Vitro Testing Services Revenue by Application (2021-2032)
- 6.3 Global Cosmetic In Vitro Testing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 SGS
- 7.1.1 SGS Company Information
- 7.1.2 SGS Business Overview
- 7.1.3 SGS Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.1.4 SGS Cosmetic In Vitro Testing Services Product Portfolio
- 7.1.5 SGS Recent Developments
- 7.2 Intertek
- 7.2.1 Intertek Company Information
- 7.2.2 Intertek Business Overview
- 7.2.3 Intertek Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.2.4 Intertek Cosmetic In Vitro Testing Services Product Portfolio
- 7.2.5 Intertek Recent Developments
- 7.3 Eurofins Scientific
- 7.3.1 Eurofins Scientific Company Information
- 7.3.2 Eurofins Scientific Business Overview
- 7.3.3 Eurofins Scientific Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.3.4 Eurofins Scientific Cosmetic In Vitro Testing Services Product Portfolio
- 7.3.5 Eurofins Scientific Recent Developments
- 7.4 Abich
- 7.4.1 Abich Company Information
- 7.4.2 Abich Business Overview
- 7.4.3 Abich Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.4.4 Abich Cosmetic In Vitro Testing Services Product Portfolio
- 7.4.5 Abich Recent Developments
- 7.5 XCellR8
- 7.5.1 XCellR8 Company Information
- 7.5.2 XCellR8 Business Overview
- 7.5.3 XCellR8 Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.5.4 XCellR8 Cosmetic In Vitro Testing Services Product Portfolio
- 7.5.5 XCellR8 Recent Developments
- 7.6 ImQuest BioSciences
- 7.6.1 ImQuest BioSciences Company Information
- 7.6.2 ImQuest BioSciences Business Overview
- 7.6.3 ImQuest BioSciences Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.6.4 ImQuest BioSciences Cosmetic In Vitro Testing Services Product Portfolio
- 7.6.5 ImQuest BioSciences Recent Developments
- 7.7 INVITRO-CONNECT
- 7.7.1 INVITRO-CONNECT Company Information
- 7.7.2 INVITRO-CONNECT Business Overview
- 7.7.3 INVITRO-CONNECT Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.7.4 INVITRO-CONNECT Cosmetic In Vitro Testing Services Product Portfolio
- 7.7.5 INVITRO-CONNECT Recent Developments
- 7.8 Labcorp
- 7.8.1 Labcorp Company Information
- 7.8.2 Labcorp Business Overview
- 7.8.3 Labcorp Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.8.4 Labcorp Cosmetic In Vitro Testing Services Product Portfolio
- 7.8.5 Labcorp Recent Developments
- 7.9 Bio-Rad Laboratories
- 7.9.1 Bio-Rad Laboratories Company Information
- 7.9.2 Bio-Rad Laboratories Business Overview
- 7.9.3 Bio-Rad Laboratories Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Bio-Rad Laboratories Cosmetic In Vitro Testing Services Product Portfolio
- 7.9.5 Bio-Rad Laboratories Recent Developments
- 7.10 Qiagen
- 7.10.1 Qiagen Company Information
- 7.10.2 Qiagen Business Overview
- 7.10.3 Qiagen Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.10.4 Qiagen Cosmetic In Vitro Testing Services Product Portfolio
- 7.10.5 Qiagen Recent Developments
- 7.11 GE Healthcare
- 7.11.1 GE Healthcare Company Information
- 7.11.2 GE Healthcare Business Overview
- 7.11.3 GE Healthcare Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.11.4 GE Healthcare Cosmetic In Vitro Testing Services Product Portfolio
- 7.11.5 GE Healthcare Recent Developments
- 7.12 Charles River Laboratories International
- 7.12.1 Charles River Laboratories International Company Information
- 7.12.2 Charles River Laboratories International Business Overview
- 7.12.3 Charles River Laboratories International Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.12.4 Charles River Laboratories International Cosmetic In Vitro Testing Services Product Portfolio
- 7.12.5 Charles River Laboratories International Recent Developments
- 7.13 Catalent
- 7.13.1 Catalent Company Information
- 7.13.2 Catalent Business Overview
- 7.13.3 Catalent Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.13.4 Catalent Cosmetic In Vitro Testing Services Product Portfolio
- 7.13.5 Catalent Recent Developments
- 7.14 Evotec Cyprotex
- 7.14.1 Evotec Cyprotex Company Information
- 7.14.2 Evotec Cyprotex Business Overview
- 7.14.3 Evotec Cyprotex Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.14.4 Evotec Cyprotex Cosmetic In Vitro Testing Services Product Portfolio
- 7.14.5 Evotec Cyprotex Recent Developments
- 7.15 Promega
- 7.15.1 Promega Company Information
- 7.15.2 Promega Business Overview
- 7.15.3 Promega Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.15.4 Promega Cosmetic In Vitro Testing Services Product Portfolio
- 7.15.5 Promega Recent Developments
- 7.16 Gentronix Limited
- 7.16.1 Gentronix Limited Company Information
- 7.16.2 Gentronix Limited Business Overview
- 7.16.3 Gentronix Limited Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 7.16.4 Gentronix Limited Cosmetic In Vitro Testing Services Product Portfolio
- 7.16.5 Gentronix Limited Recent Developments
8 North America
- 8.1 North America Cosmetic In Vitro Testing Services Revenue (2021-2032)
- 8.2 North America Cosmetic In Vitro Testing Services Revenue by Type (2021-2032)
- 8.2.1 North America Cosmetic In Vitro Testing Services Revenue by Type (2021-2026)
- 8.2.2 North America Cosmetic In Vitro Testing Services Revenue by Type (2027-2032)
- 8.3 North America Cosmetic In Vitro Testing Services Revenue Share by Type (2021-2032)
- 8.4 North America Cosmetic In Vitro Testing Services Revenue by Application (2021-2032)
- 8.4.1 North America Cosmetic In Vitro Testing Services Revenue by Application (2021-2026)
- 8.4.2 North America Cosmetic In Vitro Testing Services Revenue by Application (2027-2032)
- 8.5 North America Cosmetic In Vitro Testing Services Revenue Share by Application (2021-2032)
- 8.6 North America Cosmetic In Vitro Testing Services Revenue by Country
- 8.6.1 North America Cosmetic In Vitro Testing Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Cosmetic In Vitro Testing Services Revenue by Country (2021-2026)
- 8.6.3 North America Cosmetic In Vitro Testing Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Cosmetic In Vitro Testing Services Revenue (2021-2032)
- 9.2 Europe Cosmetic In Vitro Testing Services Revenue by Type (2021-2032)
- 9.2.1 Europe Cosmetic In Vitro Testing Services Revenue by Type (2021-2026)
- 9.2.2 Europe Cosmetic In Vitro Testing Services Revenue by Type (2027-2032)
- 9.3 Europe Cosmetic In Vitro Testing Services Revenue Share by Type (2021-2032)
- 9.4 Europe Cosmetic In Vitro Testing Services Revenue by Application (2021-2032)
- 9.4.1 Europe Cosmetic In Vitro Testing Services Revenue by Application (2021-2026)
- 9.4.2 Europe Cosmetic In Vitro Testing Services Revenue by Application (2027-2032)
- 9.5 Europe Cosmetic In Vitro Testing Services Revenue Share by Application (2021-2032)
- 9.6 Europe Cosmetic In Vitro Testing Services Revenue by Country
- 9.6.1 Europe Cosmetic In Vitro Testing Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Cosmetic In Vitro Testing Services Revenue by Country (2021-2026)
- 9.6.3 Europe Cosmetic In Vitro Testing Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Cosmetic In Vitro Testing Services Revenue (2021-2032)
- 10.2 China Cosmetic In Vitro Testing Services Revenue by Type (2021-2032)
- 10.2.1 China Cosmetic In Vitro Testing Services Revenue by Type (2021-2026)
- 10.2.2 China Cosmetic In Vitro Testing Services Revenue by Type (2027-2032)
- 10.3 China Cosmetic In Vitro Testing Services Revenue Share by Type (2021-2032)
- 10.4 China Cosmetic In Vitro Testing Services Revenue by Application (2021-2032)
- 10.4.1 China Cosmetic In Vitro Testing Services Revenue by Application (2021-2026)
- 10.4.2 China Cosmetic In Vitro Testing Services Revenue by Application (2027-2032)
- 10.5 China Cosmetic In Vitro Testing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Cosmetic In Vitro Testing Services Revenue (2021-2032)
- 11.2 Asia Cosmetic In Vitro Testing Services Revenue by Type (2021-2032)
- 11.2.1 Asia Cosmetic In Vitro Testing Services Revenue by Type (2021-2026)
- 11.2.2 Asia Cosmetic In Vitro Testing Services Revenue by Type (2027-2032)
- 11.3 Asia Cosmetic In Vitro Testing Services Revenue Share by Type (2021-2032)
- 11.4 Asia Cosmetic In Vitro Testing Services Revenue by Application (2021-2032)
- 11.4.1 Asia Cosmetic In Vitro Testing Services Revenue by Application (2021-2026)
- 11.4.2 Asia Cosmetic In Vitro Testing Services Revenue by Application (2027-2032)
- 11.5 Asia Cosmetic In Vitro Testing Services Revenue Share by Application (2021-2032)
- 11.6 Asia Cosmetic In Vitro Testing Services Revenue by Country
- 11.6.1 Asia Cosmetic In Vitro Testing Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Cosmetic In Vitro Testing Services Revenue by Country (2021-2026)
- 11.6.3 Asia Cosmetic In Vitro Testing Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Cosmetic In Vitro Testing Services Revenue (2021-2032)
- 12.2 SAMEA Cosmetic In Vitro Testing Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Cosmetic In Vitro Testing Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Cosmetic In Vitro Testing Services Revenue by Type (2027-2032)
- 12.3 SAMEA Cosmetic In Vitro Testing Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Cosmetic In Vitro Testing Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Cosmetic In Vitro Testing Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Cosmetic In Vitro Testing Services Revenue by Application (2027-2032)
- 12.5 SAMEA Cosmetic In Vitro Testing Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Cosmetic In Vitro Testing Services Revenue by Country
- 12.6.1 SAMEA Cosmetic In Vitro Testing Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Cosmetic In Vitro Testing Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Cosmetic In Vitro Testing Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst